Table of Contents
Chapter 1. Global Antifungal Drugs Market Executive Summary
1.1. Global Antifungal Drugs Market Size & Forecast (2024-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Drug Class
1.3.2. By Indication
1.3.3. By Dosage Form
1.3.4. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Antifungal Drugs Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Antifungal Drugs Market Dynamics
3.1. Market Drivers
3.1.1. Growing Prevalence of Fungal Infections
3.1.2. Increase in Hospital-Acquired Infections
3.1.3. Advancements in Antifungal Medications
3.2. Market Challenges
3.2.1. High Costs of Treatment
3.2.2. Resistance to Antifungal Drugs
3.3. Market Opportunities
3.3.1. Expansion in Emerging Markets
3.3.2. Development of Novel Antifungal Drugs
3.3.3. Strategic Collaborations and Partnerships
Chapter 4. Global Antifungal Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Antifungal Drugs Market Size & Forecasts by Drug Class 2024-2032
5.1. Segment Dashboard
5.2. Global Antifungal Drugs Market: Drug Class Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Azoles
5.2.2. Echinocandins
5.2.3. Polyenes
5.2.4. Allylamines
5.2.5. Others
Chapter 6. Global Antifungal Drugs Market Size & Forecasts by Indication 2024-2032
6.1. Segment Dashboard
6.2. Global Antifungal Drugs Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Dermatophytosis
6.2.2. Aspergillosis
6.2.3. Candidiasis
6.2.4. Others
Chapter 7. Global Antifungal Drugs Market Size & Forecasts by Dosage Form 2024-2032
7.1. Segment Dashboard
7.2. Global Antifungal Drugs Market: Dosage Form Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Oral Drugs
7.2.2. Ointments
7.2.3. Powders
7.2.4. Others
Chapter 8. Global Antifungal Drugs Market Size & Forecasts by Distribution Channel 2024-2032
8.1. Segment Dashboard
8.2. Global Antifungal Drugs Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Hospital Pharmacies
8.2.2. Retail Pharmacies
8.2.3. Others
Chapter 9. Global Antifungal Drugs Market Size & Forecasts by Region 2024-2032
9.1. North America Antifungal Drugs Market
9.1.1. U.S. Antifungal Drugs Market
9.1.1.1. Drug Class breakdown size & forecasts, 2024-2032
9.1.1.2. Indication breakdown size & forecasts, 2024-2032
9.1.1.3. Dosage Form breakdown size & forecasts, 2024-2032
9.1.1.4. Distribution Channel breakdown size & forecasts, 2024-2032
9.1.2. Canada Antifungal Drugs Market
9.2. Europe Antifungal Drugs Market
9.2.1. U.K. Antifungal Drugs Market
9.2.2. Germany Antifungal Drugs Market
9.2.3. France Antifungal Drugs Market
9.2.4. Spain Antifungal Drugs Market
9.2.5. Italy Antifungal Drugs Market
9.2.6. Rest of Europe Antifungal Drugs Market
9.3. Asia-Pacific Antifungal Drugs Market
9.3.1. China Antifungal Drugs Market
9.3.2. India Antifungal Drugs Market
9.3.3. Japan Antifungal Drugs Market
9.3.4. Australia Antifungal Drugs Market
9.3.5. South Korea Antifungal Drugs Market
9.3.6. Rest of Asia Pacific Antifungal Drugs Market
9.4. Latin America Antifungal Drugs Market
9.4.1. Brazil Antifungal Drugs Market
9.4.2. Mexico Antifungal Drugs Market
9.4.3. Rest of Latin America Antifungal Drugs Market
9.5. Middle East & Africa Antifungal Drugs Market
9.5.1. Saudi Arabia Antifungal Drugs Market
9.5.2. South Africa Antifungal Drugs Market
9.5.3. Rest of Middle East & Africa Antifungal Drugs Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Novartis AG
10.1.2. Pfizer, Inc.
10.1.3. Bayer AG
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Novartis AG
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Pfizer, Inc.
10.3.3. Bayer AG
10.3.4. Sanofi
10.3.5. Merck & Co., Inc.
10.3.6. GlaxoSmithKline plc
10.3.7. Abbott
10.3.8. Glenmark
10.3.9. Enzon Pharmaceuticals, Inc.
10.3.10. Astellas Pharma, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes